D-121
Today is 2022. 05. 17

Scientific Program

  • Home
  • Program
  • Scientific Program
September 15(Thu)
12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM
September 15(Thu) 12:50 - 14:20
Symposium 1
Optimal risk factor control in patients with DM

Chairperson

Panels

12:50 - 13:10

How much treatable residual risk do we really have?

Bo Kyung Koo (Seoul National University, Korea)

13:10 - 13:30

Concept of multiple risk factor control in DM

Hyun Min Kim (Chung-Ang University, Korea)

13:30 - 13:50

Is there special tool for control of diabetic dyslipidemia?

Nam Hoon Kim (Korea University, Korea)

13:50 - 14:20

Discussion

September 15(Thu)
14:30 - 15:30
Oral Presentation 1
September 15(Thu) 14:30 - 15:30
Oral Presentation 1

Chairperson

Panels

14:30 - 14:37

14:37 - 14:44

14:44 - 14:51

14:51 - 14:58

14:58 - 15:05

15:05 - 15:30

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective
September 15(Thu) 15:30 - 17:00
Symposium 4
Update on coronary CT: risk marker, monitoring tool & future perspective

Chairperson

Panels

15:30 - 15:50

Calcium score to predict future CV event

Eun-Jung Rhee (Sungkunkwan University, Korea)

15:50 - 16:10

What are unsolved issues in the coronary CT research?

Iksung Cho (Yonsei University, Korea)

16:10 - 16:30

New markers of coronary CT for future CV event

Min Jae Cha (Chung-Ang University, Korea)

16:30 - 17:00

Discussion

Breakfast & Luncheon Sympoisum
September 15(Thu)
15:30 - 17:00
Luncheon Symposium 1
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 1

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 15(Thu)
12:50 - 14:20
Basic Research Workshop 1
Lipid metabolism & metabolic disorders
September 15(Thu) 10:00 - 10:50
Basic Research Workshop 1 Lipid metabolism & metabolic disorders

Chairperson

Panels

12:50 - 13:10

Cellular lipid trafficking & cholesterol homeostasis

Young Mi Park (Ewha Womans University, Korea)

13:10 - 13:30

Identification of novel lipid droplet factors in macrophage foam cells

Mireille Ouime (University of Ottawa, Canada)

13:30 - 13:50

Nutrient sensing mechanism for LDLR related protein LRP6

Eek-hoon Jho (University of Seoul, Korea)

13:50 - 14:20

Discussion

September 15(Thu)
14:30 - 15:30
Oral Presentation 2 (APSAVD Young Investigator Session)
September 15(Thu) 14:30 - 15:30
Oral Presentation 2 (APSAVD Young Investigator Session)

Chairperson

Panels

14:30 - 14:37

14:37 - 14:44

14:44 - 14:51

14:51 - 14:58

14:58 - 15:05

15:05 - 15:20

Discussion

September 15(Thu)
15:30 - 17:00
Basic Research Workshop 2
SMC plasticity in plaque stability
September 15(Thu) 15:30 - 17:00
Basic Research Workshop 2 SMC plasticity in plaque stability

Chairperson

Panels

15:30 - 15:50

Role of TCF21 disease gene in SMC phenotype modulation

Juyong Brian Kim (Stanford University, USA)

15:50 - 16:10

Targeting SMC phenotypic switching in vascular disease

Chang-Seon Myung (Chungnam National University, Korea)

16:10 - 16:30

Regulation of phenotypic plasticity of vascular smooth muscle cells

Sun Sik Bae (Pusan National University, Korea)

16:30 - 17:00

Discussion

Breakfast & Luncheon Symposium
September 15(Thu)
12:00 - 12:50
Luncheon Symposium 2
September 15(Thu) 12:00 - 12:50
Luncheon Symposium 2

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 15(Thu)
12:50 - 14:20
Symposium 2
Novel risk factors & intervention targets in atherosclerosis
September 15(Thu) 12:50 - 14:20
Symposium 2 Novel risk factors & intervention targets in atherosclerosis

Chairperson

Panels

12:50 - 13:10

Biological & clinical influence of air pollution on metabolism & vasculature

Seung-Pyo Lee (Seoul National University, Korea)

13:10 - 13:30

Role of T-cell cholesterol efflux pathways in aging, inflammation, & atherosclerosis

Marit Westerterp (University of Groningen, Netherlands)

13:30 - 13:50

Circadian rhythm as risk & treatment target in ASCVD

Mahmood Hussain (New York University, USA)

13:50 - 14:20

Discussion

September 15(Thu)
12:50 - 14:20
Symposium 3
NAFLD, metabolic dysfunction & ASCVD
September 15(Thu) 12:50 - 14:20
Symposium 3 NAFLD, metabolic dysfunction & ASCVD

Chairperson

Panels

12:50 - 13:10

MAFLD & risk of cardiovascular disease

Yong-ho Lee (Yonsei University, Korea)

13:10 - 13:30

PDK, NAFLD, & ASCVD

Jae-Han Jeon (Kyungpook National University, Korea)

13:30 - 13:50

Recent evidence between CVD & NAFLD/NASH in Japan

Masahiro Koseki (Osaka University, Japan)

13:50 - 14:20

Discussion

September 15(Thu)
15:30 - 17:00
Symposium 5
Lipid as risk & target in cerebrovascular disease
September 15(Thu) 15:30 - 17:00
Symposium 5 (S-C-E3) Lipid as risk & target in cerebrovascular disease

Chairperson

Panels

15:30 - 15:50

Remnant cholesterol, Lp(a) & stroke

Yong Jae Kim (The Catholic University, Korea)

15:50 - 16:10

Lipid management for patients with non-atherosclerotic stroke

Woo-Keun Seo (Sungkyunkwan University, Korea)

16:10 - 16:30

Target LDL-C level for patiegray_bgts with cerebrovascular disease

Kazuo Kitagawa (Tokyo women medical hospital, Japan)

16:30-17:00

Discussion

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 6
Adipose tissue & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 6 Adipose tissue & atherosclerosis

Chairperson

Panels

09:45 - 10:05

Novel mechanisms for lipogenesis regulation

Gina Lee (University of California Irvine, USA)

10:05 - 10:25

Local & systemic effect of organ fat deposition

Sung Hee Choi (Seoul National University, Korea)

10:25 - 10:45

Liver & adipose tissue in atherosclerosis

Ji Young Lee (University of Connecticut, USA)

10:45 - 11:15

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

TBD

TBD

September 16(Fri)
13:35 - 15:05
Symposium 10
Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution
September 16(Fri) 13:35 - 15:05
Symposium 10 Debate on developing risk grouping in Korea: current status, comparison with foreign, & solution

Chairperson

Panels

13:35 - 13:55

Current evidence on risk stratifying factors in Koreans

Ji Hye Huh (Hallym University, Korea)

13:55 - 14:15

How much different event risk do Koreans have compared to European descendants?

Song Vogue Ahn (Ewha Womans University, Korea)

14:15 - 14:35

How to select of low risk individuals to avoid pharmacotherapy?

Hack-Lyoung Kim (Seoul National University, Korea)

14:35 - 15:05

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 3
September 16(Fri) 15:15 - 16:15
Oral Presentation 3

Chairperson

Panels

15:15 - 15:22

15:22 - 15:29

15:29 - 15:36

15:36 - 15:43

15:43 - 15:50

15:50 - 16:15

Discussion

September 16(Fri)
16:15 - 17:45
Symposium 13
Debate on new Korean guidelines on dyslipidemia: treatment
September 16(Fri) 16:15 - 17:45
Symposium 13 Debate on new Korean guidelines on dyslipidemia; treatment

Chairperson

Panels

16:15 - 16:35

Korean evidence on target LDL-C levels

Min Kyoung Moon (Seoul National University, Korea)

16:35 - 16:55

Are current Western LDL-C targets for each risk groups cost-effective in Koreans?

Sang-Hyun Kim (Seoul National University, Korea)

16:55 - 17:15

When is clinically appropriate to start anti-PCSK9 Abs?

Chang-Wook Nam (Keimyung University, Korea)

17:15 - 17:45

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 1
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 1

Chairperson

Panels

08:00 - 08:20

08:20 - 08:30

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 3
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 3

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 7
New regulators of dyslipidemia & atherosclerosis
September 16(Fri) 09:45 - 11:15
Symposium 7 New regulators of dyslipidemia & atherosclerosis

Chairperson

Panels

09:45 - 10:05

Validation of metabolic targets in adipose tissue for ASCVD

Mete Civelek (University of Virginia, USA)

10:05 - 10:25

Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis & paracrine fibrotic signalling

Judith Sluimer (Maastricht University, Netherlands)

10:25 - 10:45

Recent single cell findings for novel immune & immune-like cell actions in atherosclerosis

Jae-Hoon Choi (Hanyang University, Korea)

10:45 - 11:15

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

TBD

TBD

September 16(Fri)
13:35 - 15:05
Food and Nutrition Workshop
Cardiometabolic disease & customized nutrition management
September 16(Fri) 13:35 - 15:05
Food and Nutrition Workshop Cardiometabolic disease & customized nutrition management

Chairperson

Panels

13:35 - 13:55

Customized functional food based on big data

Jiyoung Kim (Seoul National University, Korea)

13:55 - 14:15

Customized prevention of metabolic disease in Koreans using omics technology

Min Joo Kim (Hannam University, Korea)

14:15 - 14:35

Healthcare program using digital health device

Young In Kim (Noom Inc., Korea)

14:35 - 15:05

Discussion

September 16(Fri)
15:15 - 16:15
Oral Presentation 4
September 16(Fri) 15:15 - 16:15
Oral Presentation 4

Chairperson

Panels

15:15 - 15:22

15:22 - 15:29

15:29 - 15:36

15:36 - 15:43

15:43 - 15:50

15:50 - 16:15

Discussion

September 16(Fri)
16:15 - 17:45
Publication Committee Session
September 16(Fri) 16:15 - 17:45
Publication Committee Session

Chairperson

Panels

Breakfast & Luncheon Symposium
September 16(Fri)
08:00 - 09:00
Breakfast Symposium 2
September 16(Fri) 08:00 - 09:00
Breakfast Symposium 2

Chairperson

Panels

08:00 - 08:20

08:20 - 08:30

September 16(Fri)
12:00 - 12:50
Luncheon Symposium 4
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 4

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 16(Fri)
09:00 - 09:40
Plenary Lecture 1
September 16(Fri) 09:00 - 09:40
Plenary Lecture 1

Chairperson

Target discovery & drug development for atherosclerosis in 2020's

Sekar Kathiresan (Verve therapeutics, USA)

September 16(Fri)
09:45 - 11:15
Symposium 8
High CV risk group: Was it properly defined?
September 16(Fri) 09:45 - 11:15
Symposium 8 High CV risk group: Was it properly defined?

Chairperson

Panels

09:45 - 10:05

What is the role of a polygenic risk score in CV risk assessment?

Amit Khera (Verve Therapeutics, USA)

10:05 - 10:25

Refinement of CV risk in current "very high" & "high" risk groups

Hyeon Chang Kim (Yonsei University, Korea)

10:25 - 10:45

Risk stratification according to age groups in new prevention guidelines

Kwang-il Kim (Seoul National University, Korea)

10:45 - 11:15

Discussion

September 16(Fri)
11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)
September 16(Fri) 11:30 - 12:00
Plenary Lecture 2 (APSAVD:Ding Lecture)

Chairperson

Recent developments in the treatment of familial hypercholesterolaemia & other familial lipid disorders

Brian Tomlinson (Macau University, China)

September 16(Fri)
12:55 - 13:35
Plenary Lecture 3
September 16(Fri) 12:55 - 13:35
Plenary Lecture 3

Chairperson

TBD

TBD

September 16(Fri)
13:35 - 15:05
Symposium 11
Inflammation in progression & inhibition of atherosclerosis
September 16(Fri) 13:35 - 15:05
Symposium 11 Inflammation in progression & inhibition of atherosclerosis

Chairperson

Panels

13:35 - 13:55

Macrophage diversity in inflammation & homeostasis

Ichiro Manabe (Chiba University, Japan)

13:55 - 14:15

Inflammation & hematopoiesis in atherosclerosis

Katey Rayner (University of Ottawa, Canada )

14:15 - 14:35

Immune cell activities in aortic aneurysm

Seung-Jun Lee (Yonsei University, Korea)

14:35 - 15:05

Discussion

September 16(Fri)
15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence and Young Investigator Scientific Excellence Award Lecture
September 16(Fri) 15:15 - 16:15
2022 KSoLA Awards for Scientific Excellence and Young Investigator Scientific Excellence Award Lecture

Chairperson

Panels

September 16(Fri)
16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium)
Impact of aging of vascular cells on atherosclerosis & its protection
September 16(Fri) 16:15 - 17:45
Symposium 14 (JAS/KSoLA Joint Symposium) Impact of aging of vascular cells on atherosclerosis & its protection

Chairperson

Panels

16:15 - 16:35

Aging as risk factor and therapeutic target in atherosclerosis

Sungha Park (Yonsei University, Korea)

16:35 - 16:55

New target genes & molecules for vascular aging

Tohru Minamino (Juntendo University, Japan)

16:55 - 17:15

What effect do cardiovascular medications & diet have on vascular aging?

Kenichi Tsujita (Kumamoto University, Japan)

17:15 - 17:45

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 5
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 5

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 16(Fri)
09:45 - 11:15
Symposium 9
Update on non-pharmacological control of ASCVD risk
September 16(Fri) 09:45 - 11:15
Symposium 9 Update on non-pharmacological control of ASCVD risk

Chairperson

Panels

09:45 - 10:05

Update on heart-healthy diet studies in the past decade

Oh Yoen Kim (Dong-A University, Korea)

10:05 - 10:25

Exercise & inflammation in atherosclerosis

Mattias Nahrendorf (Harvard Medical School, USA)

10:25 - 10:45

Effect of different diets on circulating lipoproteins

Frank M. Sacks

10:45 - 11:15

Discussion

September 16(Fri)
11:30 - 12:00
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
TBD
September 16(Fri) 11:30 - 12:00
Symposium 12 (IAS/APSAVD/JAS Joint Symposium)
TBD

Chairperson

Panels

13:35 - 13:55

13:55 - 14:15

14:15 - 14:35

14:35 - 15:05

Discussion

September 16(Fri)
16:15 - 17:45
Symposium 15 (APSAVD Symposium)
TBD
September 16(Fri) 16:15 - 17:45
Symposium 15 (APSAVD Symposium)
TBD

Chairperson

Panels

16:15 - 16:35

Impact of risk factors & medications on COVID19 outcomes

TBD

16:35 - 16:55

Effect of COVID19 on dyslipidemia & vascular disease

TBD

16:55 - 17:15

Benefit & harm of COVID19 vaccines in ASCVD

TBD

17:15 - 17:45

Discussion

Breakfast & Luncheon Symposium
September 16(Fri)
12:00 - 12:50
Luncheon Symposium 6
September 16(Fri) 12:00 - 12:50
Luncheon Symposium 6

Chairperson

Panels

12:00 - 12:20

12:20 - 12:30

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 16
Current issues in severe dyslipidemia
September 17(Sat) 09:45 - 11:15
Symposium 16 Current issues in severe dyslipidemia

Chairperson

Panels

09:45 - 10:05

What is currently best & changing in treatment of adults with FH?

Won Jae Lee (Seoul National University, Korea)

10:05 - 10:25

Update on familial vs mulitifactorial chylomicronemia syndrome

Heung Yong Jin (Jeonbuk National University, Korea)

10:25 - 10:45

Understanding role of ANGPTL3 & neighbor molecules

Hun-Jun Park (The Catholic University, Korea)

10:45 - 11:15

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Panels

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 5
September 17(Sat) 13:35 - 14:35
Oral Presentation 5

Chairperson

Panels

13:35 - 13:42

13:42 - 13:49

13:49 - 13:56

13:56 - 14:03

14:03 - 14:10

14:10 - 14:35

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?
September 17(Sat) 14:45 - 16:15
Symposium 20
How will new technologies change our research & patient care in ASCVD?

Chairperson

Panels

14:45 - 15:05

Tips for performing nationwide big cohort studies

Pil-Sung Yang (Cha University, Korea)

15:05 - 15:25

Advance of AI utility in past 5 years in ASCVD care: overview

Jun Hwan Cho (Chung-Ang University, Korea)

15:25 - 15:45

Device-based care for CV risk factors

Hak Seung Lee (Medical AI, Korea)

15:45 - 16:15

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 3
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 3

Chairperson

Panels

08:00 - 08:20

08:20 - 08:30

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 7
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 7

Chairperson

Panels

12:05 - 12:25

12:25 - 12:35

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Panels

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 17
Emerging targets & drug platforms in dyslipidemia & atherosclerosis
September 17(Sat) 09:45 - 11:15
Symposium 17 Emerging targets & drug platforms in dyslipidemia & atherosclerosis

Chairperson

Panels

09:45 - 10:05

Impact of lipases on human dyslipidemia & atherosclerosis

Hayato Tada (Kanazawa University, Japan)

10:05 - 10:25

Screening new genes for therapeutics against dyslipidemia & atherosclerosis

Alan Remaley (National Institutes of Health, USA)

10:25 - 10:45

Understanding strength & limitation of platforms in drug development

Dong Ki Lee (OliX Pharmaceuticals, Korea)

10:45 - 11:15

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Panels

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
13:35 - 14:35
Oral Presentation 6
September 17(Sat) 13:35 - 14:35
Oral Presentation 6

Chairperson

Panels

13:35 - 13:42

13:42 - 13:49

13:49 - 13:56

13:56 - 14:03

14:03 - 14:10

14:10 - 14:35

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 21
New concepts in vascular biology
September 17(Sat) 14:45 - 16:15
Symposium 21 New concepts in vascular biology

Chairperson

Panels

14:45 - 15:05

What's new in vascular calcification in atherosclerosis?

In-Kyu Lee (Kyungpook National University, Korea)

15:05 - 15:25

Celluar senescence in atherosclerosis

Jae-Ryong Kim (Yeungnam University, Korea)

15:25 - 15:45

Extracellular vesicles & endothelial cells

Kihwan Kwon (Ewha Womans University, Korea)

15:45 - 16:15

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 4
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 4

Chairperson

Panels

08:00 - 08:20

08:20 - 08:30

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 8
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 8

Chairperson

Panels

12:05 - 12:25

12:25 - 12:35

September 17(Sat)
09:00 - 09:40
Plenary Lecture 4
September 17(Sat) 09:00 - 09:40
Plenary Lecture 4

Chairperson

Panels

New look at PCSK9 metabolism & its clinical implication

Sergio Fazio (Regeneron Pharmaceuticals, USA)

September 17(Sat)
09:45 - 11:15
Symposium 18
Role & unsolved issues of novel lipid-modifying agents
September 17(Sat) 09:45 - 11:15
Symposium 18 Role & unsolved issues of novel lipid-modifying agents

Chairperson

Panels

09:45 - 10:05

Challenges & perspective of drugs for Lp(a)

Gisette Reyes-Soffer (Columbia University, USA)

10:05 - 10:25

For whom & how much will bempedoic acid work?

Raul Santos (University of São Paulo, Brazil)

10:25 - 10:45

Recent trial results of new drugs targeting TG rich lipoprotein

Eun Ho Choo (The Catholic University, Korea)

10:45 - 11:15

Discussion

September 17(Sat)
11:25 - 12:05
Plenary Lecture 5
September 17(Sat) 11:25 - 12:05
Plenary Lecture 5

Chairperson

Panels

Best approach to cardio & cerebrovascular health in the elderly

Hidenori Arai
(National Center for Geriatrics and Gerontology, Japan)

September 17(Sat)
13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)
September 17(Sat) 13:00 - 13:30
Plenary Lecture 6 (APSAVD:Yamamoto Lecture)

Chairperson

Up close & personal with vascular diseases: the role of precision medicine

Maria Teresa Abola (University of Philippines, Philippines)

September 17(Sat)
14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium)
Sex difference in dyslipidemia & atherosclerosis
September 17(Sat) 14:45 - 16:15
Symposium 22 (TSLA/KSoLA Joint Symposium) Sex difference in dyslipidemia & atherosclerosis

Chairperson

Panels

14:45 - 15:05

Characteristics of dyslipidemia & ASCVD of women in Korea

Seong-Mi Park (Korea University, Korea)

15:05 - 15:25

Sex difference in diagnosis & treatment of ASCVD: what do we need to improve in women?

Ping-Yen Liu (National Cheng Kung University, Taiwan)

15:25 - 15:45

Is there difference of response to lipid-lowering therapy in women?

Chih-Fan Yeh (National Taiwan University, Taiwan)

15:45 - 16:15

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
08:00 - 09:00
Breakfast Symposium 5
September 17(Sat) 08:00 - 09:00
Breakfast Symposium 5

Chairperson

Panels

08:00 - 08:20

08:20 - 08:30

September 17(Sat)
12:05 - 12:55
Luncheon Symposium 9
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 9

Chairperson

Panels

12:05 - 12:25

12:25 - 12:35

September 17(Sat)
09:45 - 11:15
Symposium 19
Current nutritional knowledge in cardiometabolic health
September 17(Sat) 09:45 - 11:15
Symposium 19 Current nutritional knowledge in cardiometabolic health

Chairperson

Panels

09:45 - 10:05

Organ crosstalk under atherogenic diet

Cholsoon Jang (University of California Irvine, USA)

10:05 - 10:25

Emerging role of epigenetic regulation by nutrients in inflammation & atherosclerosis

Hyun Ju Kang (Keimyung University, Korea)

10:25 - 10:45

Transition to metabolically unhealthy status & cardiometabolic risks

Clara Yongjoo Park (Chonnam National University, Korea)

10:45 - 11:15

Discussion

September 17(Sat)
14:45 - 16:15
Symposium 23 (APSAVD Symposium)
TBD
September 17(Sat) 14:45 - 16:15
Symposium 23 (APSAVD Symposium)
TBD

Chairperson

Panels

14:45 - 15:05

Practical approach of PCSK9 Ab use in primary & secondary prevention

TBD

15:05 - 15:25

Comparison of two drug platforms (Abs & siRNA)

TBD

15:25 - 15:45

Recent studies on PCSK9 action beyond LDL-C lowering

TBD

15:45 - 16:15

Discussion

Breakfast & Luncheon Symposium
September 17(Sat)
12:05 - 12:55
Luncheon Symposium 10
September 17(Sat) 12:05 - 12:55
Luncheon Symposium 10

Chairperson

Panels

12:05 - 12:25

12:25 - 12:35